Bacterial Conjunctivitis Drug Market

Bacterial Conjunctivitis Drug Market - Size,
Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Bacterial conjunctivitis is inflammation of the outermost layer of the eye and inner area of the eyelid.
Bacterial conjunctivitis symptoms include swelling, watery eyes, and redness. Bacteria responsible for
conjunctivitis include staphylococci, haemophilus, Chlamydia trachomatis, and streptococci. Children
and geriatric population are highly prone to bacterial conjunctivitis, however, it affects people of all
age groups. The increasing cases of bacterial conjunctivitis demand efficient medication, which
supports the growth of bacterial conjunctivitis drugs market. Bacterial conjunctivitis spreads because
of poor hygiene, immune compromise, ocular diseases such as dry eye, blepharitis, and
contaminated cosmetics. It can be prevented by maintaining proper hygiene and also hand wash
reduces the chances of bacterial conjunctivitis.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/714
Rise in the prevalence of high blood pressure and increase in chronic kidney disease
Increasing incidences of bacterial conjunctivitis and availability of generic drugs to
fuel the market growth
The spread of ophthalmic bacterial infection increased the demand for antibacterial drugs for its
treatment. According to National Center for Biotechnology Information (NCBI) 2013 report, in the
U.S., there were around 6 million people affected by conjunctivitis. Bacterial conjunctivitis takes
around a week to get completely cured and fluoroquinolones are the most preferred drug for the
treatment of bacterial conjunctivitis. There are certain drugs in the market that are patented and
their patents about to expire, this, in turn, is expected to increase the market for generic drugs,
which are of less price as well. Moxeza, vigamox, besivance, and zymaxid are some of the most
successful patented drugs about to expire. After patent expiry, these drugs lose their exclusivity,
which leads to increase in use of generic drugs. The development of multi-drug resistant variants
is expected to fuel the growth of bacterial conjunctivitis drug market. The unnecessary use of
antibiotics causes the disease causing bacteria to chemically evolve themselves and become
resistant to drugs. This, in turn, may lead to the prescription of strong medication, which includes
corticosteroids and high dose of antibiotics.
Report includes chapters which deeply display the following deliverable about industry :
• Bacterial Conjunctivitis Drug Market Research Objective and Assumption
• Bacterial Conjunctivitis Drug Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Bacterial Conjunctivitis Drug Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Bacterial Conjunctivitis Drug Market, By Regions
• Bacterial Conjunctivitis Drug Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Bacterial Conjunctivitis Drug Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Bacterial Conjunctivitis Drug Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Bacterial Conjunctivitis Drug Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key Players in the Bacterial Conjunctivitis Drug Market
Some of the key players contributing to the bacterial conjunctivitis drug market
growth are, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant
Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen
Pharmaceutical Co. Ltd., and Allergan Plc. For increasing market share, the companies
adopt various strategies such as mergers and acquisitions. For instance, in 2015,
Shire acquired Foresight Biotherapeutics to increase its ophthalmic product pipeline
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/714
Bacterial Conjunctivitis Drug Market Taxonomy
By Disease Type;
• Acute Bacterial Conjunctivitis
• Chronic Bacterial Conjunctivitis
By Treatment Type;
• Fluoroquinolones
• Macrolides
• Aminoglycosides
By Route of Administration;
• Topical
• Oral
• Intravitreal
By End User;
• Hospitals
• Clinics
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report